Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Leases Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Others

GeneDx Holdings (WGS) Capital Leases (2020 - 2021)

GeneDx Holdings has reported Capital Leases over the past 2 years, most recently at $18.4 million for Q4 2021.

Quarterly Capital Leases fell 11.31% to $18.4 million in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $18.4 million through Dec 2021, down 11.31% year-over-year, with the annual reading at $18.4 million for FY2021, 11.31% down from the prior year.
Capital Leases was $18.4 million for Q4 2021 at GeneDx Holdings, down from $20.8 million in the prior quarter.
Over five years, Capital Leases peaked at $20.8 million in Q4 2020 and troughed at $18.4 million in Q4 2021.